Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain

Stroke

Volumn 41, Issue 12, 2010, Pages 2744-2749

  Xu, Huichun ^a,e   Stamova, Boryana ^a   Jickling, Glen ^a   Tian, Yingfang ^a   Zhan, Xinhua ^a   Ander, Bradley P ^a   Liu, Dazhi ^a   Turner, Renée ^a   Rosand, Jonathan ^c   Goldstein, Larry B ^d   Furie, Karen L ^c   Verro, Piero ^a   Johnston, S Claiborne ^e   Sharp, Frank R ^a   Decarli, Charles S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DUKE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; blood; gene expression profiling; inflammation; ischemia; oxidative stress; white matter

Indexed keywords

RNA;

AGED; ALZHEIMER DISEASE; ANALYSIS OF COVARIANCE; ARTICLE; BRAIN BLOOD FLOW; BRAIN DAMAGE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CLUSTER ANALYSIS; COGNITION; CONTROLLED STUDY; DETOXIFICATION; DISEASE ASSOCIATION; ENCEPHALITIS; FEMALE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENOME; HUMAN; LONG TERM POTENTIATION; MALE; MICROARRAY ANALYSIS; NERVE FIBER; NERVE REGENERATION; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOGENESIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WHITE MATTER;

AGED; ALZHEIMER DISEASE; BRAIN; CLUSTER ANALYSIS; FEMALE; HORMONES; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PRINCIPAL COMPONENT ANALYSIS; RNA; SIGNAL TRANSDUCTION;

EID: 78650415012     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.591875     Document Type: Article

References (28)

1. DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, Beiser A, D'Agostino R, Wolf PA. Measures of brain morphology and infarction in the Framingham heart study: establishing what is normal. Neurobiol Aging. 2005;26:491-510.
2. Lee DY, Fletcher E, Martinez O, Ortega M, Zozulya N, Kim J, Tran J, Buonocore M, Carmichael O, DeCarli C. Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology. 2009;73:1722-1728.
3. Longstreth Jr. WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996;27:1274-1282.
4. Gouw AA, Van Der Flier WM, Fazekas F, Van Straaten EC, Pantoni L, Poggesi A, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Scheltens P, Barkhof F, LADIS Study Group. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke. 2008;39: 1414-1420.
5. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, Kalaria RN, Forster G, Esteves F, Wharton SB, Shaw PJ, O'Brien JT, Ince PG, MRC Cognitive Function and Ageing Neuropathology Study Group. White matter lesions in an unselected cohort of the elderly: Molecular pathology suggests origin from chronic hypoperfusion injury. Stroke. 2006;37:1391-1398.
6. Romero JR, Vasan RS, Beiser AS, Au R, Benjamin EJ, Decarli C, Wolf PA, Seshadri S. Association of matrix metalloproteinases with mri indices of brain ischemia and aging. Neurobiol Aging. 2009 Jan 5 [Epub ahead of print].
7. Wright CB, Moon Y, Paik MC, Brown TR, Rabbani L, Yoshita M, DeCarli C, Sacco R, Elkind MS. Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke. 2009;40:3466-3471.
8. Tang Y, Lu A, Aronow BJ, Sharp FR. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol. 2001;50:699-707.
9. Tang Y, Xu H, Du X, Lit L, Walker W, Lu A, Ran R, Gregg JP, Reilly M, Pancioli A, Khoury JC, Sauerbeck LR, Carrozzella JA, Spilker J, Clark J, Wagner KR, Jauch EC, Chang DJ, Verro P, Broderick JP, Sharp FR. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab. 2006;26:1089-1102.
10. Xu H, Tang Y, Liu DZ, Ran R, Ander BP, Apperson M, Liu XS, Khoury JC, Gregg JP, Pancioli A, Jauch EC, Wagner KR, Verro P, Broderick JP, Sharp FR. Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke. J Cereb Blood Flow Metab. 2008;28: 1320-1328.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
12. Yoshita M, Fletcher E, Harvey D, Ortega M, Martinez O, Mungas DM, Reed BR, DeCarli CS. Extent and distribution of white matter hyperin-tensities in normal aging, MCI, and AD. Neurology. 2006;67:2192-2198.
13. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology. 2000;14:224-232.
14. Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol. 2008;65:94-100.
15. Wolf H, Ecke GM, Bettin S, Dietrich J, Gertz HJ. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry. 2000;15:803-812.
16. Scheltens P, Barkhof F, Valk J, Algra PR, Van Der Hoop RG, Nauta J, Wolters EC. White matter lesions on magnetic resonance imaging in clinically diagnosed alzheimer's disease. Evidence for heterogeneity. Brain. 1992;115(Pt 3):735-748.
17. Van Der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW, Admiraal-Behloul F, Spilt A, Bollen EL, Westendorp RG, Van Buchem M.A. Interaction of medial temporal lobe atrophy and white matter hyper-intensities in AD. Neurology. 2004;62:1862-1864.
18. Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski VC. Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Arch Neurol. 1994;51: 260-268.
19. Fornage M, Chiang YA, O'Meara ES, Psaty BM, Reiner AP, Siscovick DS, Tracy RP, Longstreth Jr. WT. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: The Cardiovascular Health Study. Stroke. 2008;39:1952-1959.
20. Simpson JE, Hosny O, Wharton SB, Heath PR, Holden H, Fernando MS, Matthews F, Forster G, O'Brien JT, Barber R, Kalaria RN, Brayne C, Shaw PJ, Lewis CE, Ince PG, Medical Research Council Cognitive Function and Ageing Study Neuropathology Group. Microarray RNA expression analysis of cerebral white matter lesions reveals changes in multiple functional pathways. Stroke. 2009;40:369-375.
21. Kearney-Schwartz A, Rossignol P, Bracard S, Felblinger J, Fay R, Boivin JM, Lecompte T, Lacolley P, Benetos A, Zannad F. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009;40:1229-1236.
22. Caroli A, Testa C, Geroldi C, Nobili F, Guerra UP, Bonetti M, Frisoni GB. Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment. J Neurol. 2007;254: 1000-1008.
23. Meixner A, Haverkamp S, Wässle H, Führer S, Thalhammer J, Kropf N, Bittner RE, Lassmann H, Wiche G, Propst F. MAP1B is required for axon guidance and is involved in the development of the central and peripheral nervous system. J Cell Biol. 2000;151:1169-1178.
24. Calzà L, Fernandez M, Giuliani A, D'Intino G, Pirondi S, Sivilia S, Paradisi M, Desordi N, Giardino L. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease. Brain Res Brain Res Rev. 2005;48:339-346.
25. Gregg C. Pregnancy, prolactin and white matter regeneration. J Neurol Sci. 2009;285:22-27.
26. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sásik R, Khanlou N, Han M, Liew CC, Tsuang MT. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. PNAS. 2005;102:15533-15538.
27. Achiron A, Gurevich M. Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis. Autoimmun Rev. 2006;5:517-522.
28. SulliVan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:261-268.